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Abstract 
Effective doctor-to-patient communication is an essential component of 
health care which is difficult due to the complicated nature of ocular 
anomalies. Glaucoma and age-related macular degeneration (AMD) are 
two very common causes of decreased vision among adults older than 55 
years. This thesis outlines the steps in composition and printing of patient-
education brochures which can be used to supplement the practitioner's 
description of the diseases. The brochures contain concise, descriptive 
statements combined with simple illustrations and are printed with large 
easy-to-read print, in both English and Spanish. They explain the nature, 
pathogenesis, treatment, and prognosis of Glaucoma and AM D. 
Introduction 
We live in an information oriented society. Decisions about health care are 
often based on available information -- good and bad. A misinformed society may be 
unaware of treatment options or seek inappropriate treatment. This results in 
unnecessary cost and jeopardizes health and welfare. In addition, failure of the 
practitioner to effectively communicate often lessens the effectiveness of prescribed 
therapy and may ultimately result in litigation. There is a need for materials which 
practitioners can use to supplement their communication efforts and at the same time 
increase public awareness. 
Statement of the Problem 
The parameters of our profession are rapidly expanding, especially in the 
direction of ocular disease detection and care. As the mean age of our population 
increases, optometrists will surely be involved in the care of Age-related Macular 
Degeneration, and Glaucoma as well as other age-related ocular problems. Effective 
professional care will involve doctor-to-patient communication and education. In 
addition, our profession will benefit from enhanced public awareness of our abilities 
and expertise in these areas. 
Project Qbjective 
The purpose of this project was to create informational brochures, written in 
both English and Spanish, that a eye doctors can use to supplement their explain of 
the nature of an ocular problem and the rationale for the treatment plan. The 
practitioner can use the diagrams in the brochure to illustrate the problem, and then 
give the brochure to the patient as an at-home reference for review of any details that 
may have been forgotten or unclear. The patient's family members and friends can 
also refer to the brochure. In addition to being a communications aid, the brochure 
can serve as a public relations aid. The practitioner can easily stamp the name, 
address and telephone number of the practice on the cover. 
Methods 
This project involved several steps: 
Step 1: selecting a subject 
As a student intern at Pacific University I saw many patients who 
had early signs of age-related macular degeneration (AMD). During an 
externship at the New York Lighthouse low vision clinic I worked with 
many patients who had severe vision loss from the disease. I also had 
similar exposure to glaucoma patients. These relatively common ocular 
diseases were largely a mystery to the patients who had them and to 
their families. However, clinical evidence shows that the prognosis of 
these diseases is significantly improved if the patient understands the 
disease and complies with the prescribed therapy. Therefore, to me the 
choice of these two topics for my project was obvious and interesting. 
Step 2: researching the subjects 
All of the information and statements in the brochures can be 
referenced to recently published articles from ophthalmological journals 
and the Journal of the American Optometric Association. I gathered 
literature on the specific topics with help from Pacific University Library 
Services using Medline database and the LION database from Southern 
College of Optometry in Memphis, Tenn. I scanned the abstracts of 
recent articles for relevance to my project. I used the Index Medicus at 
Pacific University in the same fashion. I then located the respective 
articles, photocopied them and reviewed each one individually for 
pertinent information. 
Step 3: writing the text 
The organization of the brochures can be broken down into 5 
basic categories: 
1. Introduction (why is the topic important). 
2. The nature of the disease. 
3. Contributing factors, and risk factors of the disease. 
4. Treatment and prognosis of the disease (including 
the patient's role). 
5. Illustrations to supplement the text. 
I condensed the information from the literature into basic informational 
statements under the above headings. Then I composed a text 
attempting to reflect the information in the most clear, concise and 
readable manner. This part was probably the most time consuming 
requiring literally hundreds of hours and resulting in over 20 drafts. Early 
on I made some crude sketches to help illustrate the text. I submitted the 
earliest drafts of the project to doctors and professors of optometry for 
comment on accuracy of content, and to one of my former English 
professors for critique of clarity and style. After further modification I 
submitted drafts to non-professional and non-academic people for 
general critique and comment. During this process I was aided by 
suggestions from my Pacific U. faculty thesis advisor. 
Step 4: art work and design 
The layout of the brochures is three-fold BX1 0" with a total of 6 
columns. I did the type setting using MS Word 4.0 software on a 
Macintosh computer. Another individual (see Acknowledgements), who 
has professional experience in graphic arts, composed the art work using 
my original sketches as a starting point, and provided valuable additional 
suggestions and ideas. 
Step 5: obtaining the copyright 
One can obtain a copyright for printed materials by filling out a 
form provided by the Federal Department of Copyright and Liscensure 
and returning it along with $25 and a copy of the material. It will 
subsequently appear on the list of copyrighted materials available at the 
U.S. Government Bookstore. 
Step 6: printing of the brochures 
1. Layout of text and art work to press specifications which include 
appropriate margins, spacing and format. 
2. A photographic negative is made of the art (text and diagrams). 
3. The photographic negatives are then taped down to sheets of 
mylar. 
4. Color tones for the art are screened to appropriate 
"percentages" determined by spacing of dot reproductions. In this project 
we used two colors: reflex blue and p.m.s. red. 
5. Each color tone is shot to a separate sheet of film. 
6. The photographic negatives are then "built" together and sent to 
the printer. 
7. The printer converts the negative images back to positive 
images which are hung on the press cylinders containing ink wells. Ink 
adheres to the positive image and is printed to the paper. The paper for 
this project is dull white 701b. product lithe. 
8. After the appropriate drying time the printed brochures are sent 
to the bindery where they are trimmed to size and folded. 
THE PUZZLE OF 
GLAUCOMA 
Glaucoma is a very common, yet 
very serious ocular disease. More 
than one million people in the U.S. 
are visually impaired from the 
disease, and over 67,000 are 
legally blind! Glaucoma occurs in 
many forms, but the most common 
form, called primary open-angle 
glaucoma (POAG), happens so 
slowly and so painlessly that a 
person may be completely 
unaware of it until significant 
damage has occurred. 
Glaucoma is like a puzzle. 
Researchers have yet to fully 
assemble the puzzle, but they 
have found some of its pieces. 
PUZZLE PIECE #1: 
The Optic Nerve 
When you look at an object, its 
image falls on your retina (see 
diagram). Your retina sends 
signals via the optic nerve to your 
brain where they become "vision." 
Glaucoma is a condition in 
which the optic nerve begins to 
degenerate. If left untreated it will 
result in blindness. 
PUZZLE PIECE #2: 
Intra-Ocular Pressure 
Important structures in your eye 
are nourished by a special fluid 
called aqueous humor (see 
diagram). 
High levers of intra-ocular 
pressure (lOP), which you 
usually cannot feel, may cause 
damage to the optic nerve. This 
results in a characteristic reduction 
of the field of vision, which begins 
in the peripheral or "side" vision. 
.._..__GLAUcoMA~ j OptiC--Nerve j DegeneratiOn 
Intra-ocular pressure 
Aqueous Humor 
circulation 
Iris 
( 
Optic nerve carries 
light energy from 
the eye to the brain 
/,~:::--!e._ ~ra'· . n -::-~,~ 
.... · 
Risk Factors 
Age 
Genetics 
Race 
Nearsightedness 
Aqueous humor continually 
circulates into and out of your eye. 
The circulation must be carefully 
regulated. If more fluid flows in 
and less flows out, the pressure 
inside your eye goes up. 
At first the vision loss is 
unnoticeable, but it slowly 
advances until it becomes very 
severe. 
ADDITIONAL FACTORS 
(puzzle piece #3,4,5, ........ ?) 
So far we know that glaucoma is a 
disease of the optic nerve and that it 
is associated with lOP. However, 
some people may have high lOP 
and not have glaucoma while others 
may have "normal" lOP and yet 
have the disease. 
Factors in addition to lOP 
which may place a person at risk 
are: 
1. Age. The older you are, 
the more likely you are to 
develop glaucoma. 
2. Genetics. Glaucoma 
tends to run in the family. 
3. Race. African-Americans 
are eight times more likely to 
develop glaucoma than 
people of other races. 
4. Near-sightedness. 
How and why these factors 
contribute to the disease is 
unknown, and more puzzle pieces 
have yet to be found. 
TREATMENT OF 
GLAUCOMA 
Currently there is no cure for 
glaucoma, but the disease can be 
managed to prevent vision loss. 
Treatment is aimed at lowering the 
intra-ocular pressure. Medication in 
the form of eye drops is commonly 
used to regulate the circulation of 
fluid. 
To be effective, the eye-drop method 
requires that the patient follow a strict 
schedule. Failure to use the 
medication consistently and at 
proper time intervals is the 
leading cause of glaucoma 
blindness! 
Remember, glaucoma 
(POAG) causes no pain! A patient 
will feel no improvement after taking 
the medication which is costly. and 
can be inconvenient. Complying 
with the therapy may be tough, but 
the alternative-- blindness-- is even 
tougher! 
Advanced cases of glaucoma 
and cases that don't respond to 
medication often require specific 
surgical procedures. 
PUTTING THE PIECES 
TOGETHER 
Your eye-care professional cannot 
make a diagnosis of glaucoma 
based on the presence of one or 
two of the puzzle pieces alone. Your 
doctor must carefully consider the 
characteristics of each individual. 
lOP, appearance of the optic nerve, 
visual field, age, race, and family 
history must all be considered 
together in order to begin to 
"assemble" the puzzle of glaucoma. 
©1992 J. W. Walker, OD: Author /Designer 
printed in USA Carolee Romney: Illustrator 
Robert C. Gruter: Production 
THE PUZZLE OF 
GLAUCOMA 
"My vision just isn't what it 
used to be." 
Reduced eyesight is one of the 
biggest health concerns 
associated with aging. The most 
common cause of reduced 
eyesight, which cannot be 
corrected with regular eyeglasses, 
is known as age-related macular 
degeneration (AMD). AMD is the 
leading cause of irreversible vision 
loss among elderly people in 
North America. It occurs in about 
one in ten people ages 65-7 4, and 
in about three 1n ten people over 
age 75. It is a serious problem, 
and so far researchers have found 
neither its cause nor its cure. 
What is the macula? 
The macula is the tiny area of your 
retina (see diagram below) which 
is most responsive to light-- the 
area that provides your "most 
distinct vision." 
light 
When you look at an object, the 
image of the object falls in the 
middle of the macula. The macula 
contains a high concentration of 
specialized cells called 
photoreceptors (see below). 
Photoreceptors convert light into 
nerve impulses which travel to 
your brain to become "vision." 
Normal Retina 
o 0 ooo 
How does AMD happen? 
AMD is a condition in which the 
tiny photoreceptors in the macula 
degenerate (see diagram below). 
Dry AMD 
In the "dry" form of AM D, waste 
accumulates beneath the 
photoreceptors and blocks the 
transfer of important nutrients 
from the blood stream. This 
results in a gradual loss of vision. 
In the uwet" form of AMD, blood 
vessels beneath the accumulation 
of waste begin to leak causing the 
formation of a pool of blood, fluid, 
and subsequent scar tissue. This 
can be devastating to vision! 
WetAMD 
Symptoms of "wet" AMD are: 
D sudden, rapid vision loss 
D reduced color vision 
D visual distortion 
Who will get AMD? 
Many factors place an individual at 
risk. As the name implies, age is 
the biggest risk. The older you 
get, the more likely you are to get 
some form of AM D. 
Other risk factors include: 
D family history of AMD 
D cardiovascular disease 
D high blood pressure 
D excessive exposure to 
sunlight 
D light eye color 
0 poor diet 
0 cigarette smoking 
What if you get AMD? 
Currently there is no treatment for 
the "dry" form of AMD. If it should 
progress to become "wet" AMD, 
expertly administered laser 
therapy can "coagulate" leaky 
blood vessels and slow down the 
visual loss. Certain microsurgical 
techniques may also help prevent 
severe vision loss. However; in 
order to be effective, these types 
of intervention must be done 
quickly, within hours or days! 
What can be done to avoid 
AMD? 
Many doctors suggest a few things 
to help preserve your vision: 
D Sunglasses 
D A well balanced diet 
D Vitamin supplements 
that include vitamin C, 
vitamin A, and Zinc 
D Yearly eye exams 
The most important thing 
that you can do: 
D Frequent check-ups with 
your eye doctor 
D Be aware of the 
symptoms of "wet" AM D 
D Home monitor with 
Amsler grid 
Home monitoring using an 
Amsler grid (see below) will 
enable you to detect any loss or 
distortion of central vision. If 
changes occur you must notify 
your eye doctor immediately! 
Wasted time is wasted sight! 
AMSLER GRID 
Hold the grid 12" from your face. 
Cover one eye and stare at the 
center dot (be sure to wear your 
reading glasses if you have them). 
Repeat the procedure with your 
other eye. If the lines appear 
distorted or broken, have 
your eyes examined right 
away. 
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AGE-RELATED 
MACULAR 
DEGENERATION 
La Rompecabezas de Ia 
Glaucoma 
La glaucoma es una enfermedad 
que es muy comun y muy grave. 
Mas que un millen de personas in 
los EEUU tienen dana de Ia vista 
par causa de Ia glaucoma, y i mas 
de 67,000 son ciegas! La forma 
mas comun de Ia glaucoma 
sucede gradualmente y sin dolor. 
Una persona no estara conciente 
de ella hasta que haya resultado 
en mucho dana. 
La glaucoma es como una 
rompecabezas. Los investigadores 
todavfa no han resolvado Ia 
rompecabeza, pero sf, han 
encontrado algunos de los pedazos. 
Pedazo #1 : El Nervio Optico 
Cuando Ud. mira a un objeto, Ia 
imagen del objeto llega a Ia retina 
(vease Ia diagrama). La retina 
manda senales par el nervio 6ptico 
hasta el cerebra donde se 
transforman en "Ia vista." La 
glaucoma es una condici6n en que 
el nervio 6ptico se descompone, y, 
si no se da tratamiento, resulta en 
Ia ceguera. 
( 
Pedazo #2: 
La Presion Intra-Ocular 
Estructuras inportantes del ojo 
reciben alimento par un fluido 
especial dentro del ojo (vease Ia 
diagrama). 
NiveJes altos de Ia presion 
intra-ocular (PIO), lo cual no se 
puede sentir, pueden resultar en 
mucho dana al nervio 6ptico. El 
dana causa en Ia perdida de Ia vista 
periferica, o sea, "Ia vista dell ado." 
_LA_ G-~-~~0~~: _ _ I~~~;~~r~ci~~del j Nervio Optico 
Presion Intra-ocular El Nervio Optico I Factores inportantes 
conduce informacion 
desde el ojo basta 
Circulaci6n 
Fluido 
el cerebro 
Iris 
' , "-.. , 
'-....._ ·~ 
(--~. 
~. 
La Edad 
La Genetica 
La Raza 
La Miopia 
(; -L __ 
_____ Sl_ _l_ ·-_Q 
Este fluido entra y sale del ojo 
constantemente. La entrada y 
salida se tiene que regular con 
mucho cuidado. Si mas fluido 
entre al ojo de lo que salga, Ia 
presion adentro del ojo se subira. 
AI principia no se nota Ia perdida 
de vista,pero luego va 
progresando hasta que sea muy 
grave. 
) 
Factores de mas 
(pedazos #3,4,5 ......... ?) 
Hasta aquf sabemos que Ia 
glaucoma es una enfermedad del 
nervio 6ptico y que se relaciona 
con Ia PIO. Sin embargo, muchas 
personas tienen Ia PIO alta sin 
tener Ia glaucoma, mientras que 
otras pueden tener Ia PIO normal 
y tener Ia glaucoma at.Jn. 
Factores ademas de Ia PIO 
que contribuyen a Ia glaucoma: 
D La Edad 
0 La Genetica 
0 La Raza 
0 La Miopia 
Todavfa no se sabe exactamente 
Ia manera en que estes factores 
sedan a Ia enfermedad, y aun 
mas pedazos se han de 
encontrar. 
Tratam iento de Ia 
Glaucoma 
Hoy en dfa no hay remedio para Ia 
glaucoma, sin embargo Ia 
enfermedad se puede controlar 
para que no haya perdida de Ia 
vista. La meta del tratamiento es 
Ia de rebajar Ia presion intra-ocular. 
Medicamento en forma de gotas 
para los ojos se recieta para 
controlar Ia circulaci6n del fluido. 
El exito del tratamiento exije que el 
paciente siga un horario de 
rnstalaci6n muy estricto. 
El tracaso de no usar el 
medicamento como 
corresponde es Ia causa 
mayor del Ia ceguera por Ia 
glaucoma. 
Acuerdese: jla glaucoma 
(GPAA) no causa dolor! El 
paciente no ha de sentir ninguna 
diferencia despues de usar el 
medicamento, que es muy carey 
puede ser inc6modo. El cumplir 
con el tratamiento es diflcil, perc el 
alternative -- Ia ceguera -- i es mas 
diffcil aun! 
De vez en cuando hay cases 
de Ia glaucoma que no responden 
a Ia medicina. Estes requiren tipos 
espicfficos de Ia cirugfa. 
Juntando los Pedazos 
Su doctor de los ojos no puede 
hacer el diagn6stico de Ia 
glaucoma a base de Ia presencia 
de solo uno o dos de los pedazos. 
Su doctor tiene que considerar los 
caracterfsticos de cada paciente. 
La PIO, Ia aparencia del nervio 
6ptico, Ia vista periferica, Ia edad, 
Ia raza, y las geneticas se tiene 
que tamar en cuento para que 
pueda solucionar Ia 
rombecabezas de Ia glaucoma. 
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LA 
ROMPECABEZAS 
DE LA 
GLAUCOMA 
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"La vista mia no es lo que 
era." 
La reducci6n de Ia vista ocurre con 
mucha frequencia alllegerse a Ia 
edad mas avanzada. De las 
causas que no se puede corregir 
con lentes regulares, Ia mas 
comun es una que se llama Ia 
degeneraci6n macular de Ia 
senilidad (OMS). La OMS es Ia 
causa mayor de Ia perdida de Ia 
vista entre aquellos con mayor 
edad en Norte America. Ocurre en 
1 0°/o de personas de edad 65-7 4 y 
en 30°/o de personas que tienen 
mas que 75 arias. La OMS es un 
problema bien grave, y hasta 
ahara los investigadores han 
encontrado ni Ia causa ni Ia 
remedia. 
t,Que es Ia macula? 
La macula es Ia zona pequena de 
Ia retina (vease Ia diagrama abajo) 
que es Ia mas sensible a Ia luz. 
Cuando Ud. mira a un objeto, Ia 
imagen del objeto calle en el 
centro de Ia macula. La macula 
contiene muchas celdas 
especiales que se llaman los 
fotoreceptores. Los fotoreceptores 
cambian Ia luz a "Ia vista." 
Retina Sana fotoreceptores 
vias sangrientes 
t,Que pasa en Ia OMS? 
La OMS es una condici6n en que 
los fotoreceptores de Ia macula se 
degradan (vease Ia diagrama abajo). 
OMS Seca fotoreceptores 
vias sangrientes 
roductos inutiles 
En Ia forma "seca, de Ia OMS, 
productos inutiles se juntan abajo 
de los fotoreceptores e impeden Ia 
transladaci6n de alimentos 
importantes desde Ia corriente 
sangufnea, el cual resulta en Ia 
perdida de Ia vista gradual. 
En Ia forma "mojada, de Ia OMS, 
vias sangrientes debajo de los 
productos inutiles dejan escapar Ia 
sangre y fluido, y luego se forma Ia 
cicatriz. Lo resulta do es 
extremadamente danoso a Ia vista. 
OMS Mojada fotoreceptores 
ias sangrientes 
sangre y fluido 
Los sintomas de Ia OMS "mojada" son: 
0 Ia perdida rapida de Ia vista 
0 Ia reducci6n del sentido 
del color 
D Ia distorsi6n de Ia vista 
t,A quien le pasara Ia OMS? 
Hay muchos factores que sedan a 
Ia OMS. Como implica el nombre, 
Ia edad avanzada es el factor 
mayor. Otros factores incluyen: 
D historia familiar de Ia OMS 
D infermedad cardiovascular 
D Ia presion alta 
D Ia luz del sol 
D ojos claros 
D Ia malnutrici6n 
D fumar el tobaco 
~ Y si a Ud. le resulta Ia 
OMS? 
Hoy en dia no hay tratamiento 
para Ia forma "seca" de Ia OMS. Si 
se cambia a Ia forma "mojada", 
terapia del laser se puede 
administrar para impedir el 
progreso de Ia perdida de Ia vista. 
Sin embargo, para que sea eficaz 
jSe lo necesita hacer dentro de 
pocas horas o dias! 
G Que se puede hacer para 
evitar Ia OMS? 
Muchos doctores sugieren ciertas 
maneras de conservar Ia vista 
sana: 
D gafas para el sol 
D Ia dieta sana 
D vitaminas que incluyen Ia 
vitamina C, Ia vitamina A, y 
el cine. 
D examines anuales de los 
ojos 
Lo mas importante que Ud. 
puede hacer: 
D examines frecuentes con 
su doctor 
D sea conciente de los 
sf ntomas de Ia OMS "mojada" 
0 vigilar con una reja de 
Amsler 
Vigilandose contra los cambios 
de Ia vista con una reja de 
Amsler {vease abajo) es Ia mejor 
manera de notar los cambios en Ia 
vista. Si algunos cambios se ocurren 
javisele a su doctor inmediatamente! 
i El tiempo perdido es igual que Ia 
vista peredida! 
AMSLER GRID 
Coloque Ia reja 30cm frente a su 
cara. Cubrase un ojo y mantenga Ia 
vista fijada en el punto del centro 
(no se olvide colocar sus gafas de 
leer silos tenga). Repitalo con el 
otro ojo. Si las Hneas se 
parecen quebradas o torcidas, 
obtengase un examen de los 
ojos lo antes posible. 
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LA 
DEGENERACION 
MACULAR DE LA 
SENILIDAD 
Conc/usjoa 
These brochures will be a valuable asset and tool to use for management of 
patients with glaucoma and AMD. They are readable and appealing because of their 
colorful diagrams, large print and concise sentences. The Spanish versions will be 
valuable for anyone practicing in a bi-lingual area, such as the Pacific University 
Washington County clinics. 
Future P,Qjects 
I intend to use what I have learned while doing this project to create additional 
patient information resources in the future. Future topics will include (but are not 
limited to): 
-cataracts -vision and child development 
-contact lenses -vision and safety 
-the eyes and reading -optometry vs. ophthalmology 
-multifocal lenses -diabetes and vision 
Other projects will include short informational articles with diagrams to be 
used as advertisements in newspapers. 
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